http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113711047-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_465b607edb4c88aeefb4958e154efaec |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate | 2019-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a8ab714407e88b9171de093dede677 |
| publicationDate | 2021-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113711047-A |
| titleOfInvention | Methods for providing information on the diagnosis or prognostic measures of histological severity in nonalcoholic fatty liver disease |
| abstract | The present invention relates to a method for providing information on the diagnosis or prognostic measurement of histological severity of non-alcoholic fatty liver disease. When the content of sphingomyelin is more than 1.3 times that of the normal control group, it can be considered to be related to the severity of non-alcoholic fatty liver disease. There is an increased risk associated with the severity, so that this can be effectively used for severity diagnosis or prognostic measures. |
| priorityDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.